These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1238209)

  • 1. [Changes in the C-peptide level in diabetes at glucose loading].
    Kiyono Y; Inoue Y; Kadowaki S; Iijima T; Nakata S
    Horumon To Rinsho; 1975 Sep; 23(9):907-11. PubMed ID: 1238209
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in serum C-peptide in glucose tolerance test; with special reference to diabetes and insulinoma].
    Iwaya S; Odagiri R; Tasaka J; Hirata U
    Horumon To Rinsho; 1976; 24(5):443-8. PubMed ID: 187365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in CPR and blood metabolites during glucose loading in healthy subjects and patients with various diseases].
    Sakamoto N; Hotta G
    Horumon To Rinsho; 1977 Oct; 25(10):1081-9. PubMed ID: 589807
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes of serum insulin during fasting and glucose loading before and after treatment of diabetes].
    Kosaka K; Hagura R; Ogawara H
    Dtsch Med J; 1970 Apr; 21(8):554-64. PubMed ID: 5510200
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in blood insulin level induced by intravenous or oral glucose in various types of diabetes mellitus].
    Mirouze J; Orsetti A; Lapinski H
    Diabete; 1970; 18(3):174-8. PubMed ID: 5472235
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fucose levels and their response to glucose loading in diabetics.
    Marshall AM; Georges RJ; Clarke BF; Whitby LG; Duncan LJ
    Metabolism; 1970 Feb; 19(2):114-9. PubMed ID: 4903727
    [No Abstract]   [Full Text] [Related]  

  • 8. [C-peptide from proinsulin e--theory and practice].
    Malmquist J; Lindgärde F; Almér LO; Johansson E
    Lakartidningen; 1982 Jul; 79(30-31):2716-9. PubMed ID: 6755106
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma trivalent chromium, glucose tolerance and insulin secretion in juvenile- and adult-onset diabetes mellitus.
    Gedik O; Unal S; Koray Z
    Isr J Med Sci; 1980 Aug; 16(8):563-5. PubMed ID: 6998922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the 50 g and 75 g oral glucose tolerance test in the aged subjects].
    Lee Y; Ito H; Shiraki M
    Nihon Ronen Igakkai Zasshi; 1984 Jan; 21(1):27-31. PubMed ID: 6376876
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose tolerance in subjects with family history of diabetes.
    Thirumoorthi KV; Narayanan KV; Moses SG
    Indian J Med Res; 1983 Jun; 77():909-14. PubMed ID: 6642589
    [No Abstract]   [Full Text] [Related]  

  • 12. [Insulin response to the oral glucose tolerance test in obese patients and in subjects with a family history of diabetes mellitus].
    Fernandez Feo N; Betancourt de Breña A
    Acta Cient Venez; 1988; 39(5-6):443-6. PubMed ID: 3077893
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
    Arapova SD; Zavadskiĭ PS; Marova EI
    Sov Med; 1980; (2):42-7. PubMed ID: 6987746
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of diabetes mellitus and disorders of glucose tolerance in patients after acute pancreatitis].
    Małecka-Panas E; Rogoziński R; Torzecka W; Krysiak G; Kozłowska A
    Pol Tyg Lek; 1990 May 7-14; 45(19-20):370-2. PubMed ID: 2255652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute changes in serum calcium on glucose tolerance, blood glucose, IRI and cortisol levels.
    Gerö L; Szalay F; Steczek K; Tamás G
    Horm Metab Res; 1976 Mar; 8(2):151-2. PubMed ID: 1261967
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glucose intolerance and diabetes (author's transl)].
    García H; Tapia JC; Vicuña J; De Los Ríos MG
    Rev Med Chil; 1980 Dec; 108(12):1125-9. PubMed ID: 7302410
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.
    Block MB; Rosenfield RL; Mako ME; Steiner DF; Rubenstein AH
    N Engl J Med; 1973 May; 288(22):1144-8. PubMed ID: 4633551
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on low insulin responders. Glucose tolerance and insulin response to intravenous and oral glucose challenges in 226 normal subjects and 25 subjects with mild or chemical diabetes.
    Efendić S; Cerasi E; Elander I; Thornqvist C; Fick G; Berglund B; Luft R
    Acta Endocrinol Suppl (Copenh); 1979; 224():5-32. PubMed ID: 285561
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood insulin, glucagon and glucose levels in latent diabetes mellitus determined during glucose tolerance test (effect of phenformin)].
    Tikhonova NE
    Ter Arkh; 1982; 54(10):12-6. PubMed ID: 6758166
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of obesity and maturity-onset diabetes on the kinetics of NEFA during oral glucose tolerance tests (OGTT)].
    Pasquali R; Parenti M; Della Rocca E; Rago S; Bianchi V; Gallo C; Calliva R; Melchionda N
    G Clin Med; 1979 Jul; 60(7):549-59. PubMed ID: 398303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.